Global Endoscopic Submucosal Dissection Market Size study & Forecast, by Product (Gastrosccopes and Colonoscopes, Knives, Injection Agents, Tissue Retractors, Graspers/Clips, Other Products) by Indication (Stomach Cancer, Colon Cancer, Esophageal Cancer),

Global Endoscopic Submucosal Dissection Market Size study & Forecast, by Product (Gastrosccopes and Colonoscopes, Knives, Injection Agents, Tissue Retractors, Graspers/Clips, Other Products) by Indication (Stomach Cancer, Colon Cancer, Esophageal Cancer), by End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End Users), and Regional Analysis, 2022-2029

Global Endoscopic Submucosal Dissection Market is valued at approximately USD 324.6 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.9% over the forecast period 2022-2029. Endoscopic Submucosal Dissection is responsible for removing cancer-affected areas in a Gastrointestinal Tract. Endoscopic Submucosal Dissection (ESD) is a partially advanced procedure that removes precancerous and cancerous tissues using an endoscope. This treatment seeks out cancers that are hidden beneath the GI tract's lining. Endoscopic Submucosal Dissection is a treatment option for esophageal, stomach, and colorectal cancer. The necessity for endoscopic submucosal dissection is anticipated to increase during the forecasted period due to the rising cases of cancer around the globe. Increasing rates of cancer, the growing geriatric population and the growing use of Endoscopy in detection and treatment procedures are major factors driving the growth of the endoscopic submucosal dissection market.

Global elderly populations have increased, and this has led to an increase in the prevalence of different gastrointestinal Cancers, which has led to an increase in the need for endoscopic operations. On a global scale, cancer causes around 1 in every 6 fatalities. According to the World Cancer Research Fund, the global number of breast cancer cases was around 12.5% in the year 2020, whereas Lung cancer cases were around 12.2% in the same year. According to the world health organization, there were around 1 billion people aged above 60 years globally. Due to its reduced invasiveness, ESD has proven to be extremely helpful in the treatment of older individuals. As a result, the need for ESD procedures is increased by the rising cancer incidence among senior people and the rising geriatric population leading lead the to growth of the market Furthermore, based Robot-based Endoscopic Submucosal Dissection and Innovations in traction techniques for Endoscopic Submucosal Dissection are the factors creating major market opportunities in the forecast period. However, the high risk of Endoscopic Submucosal Dissection stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Endoscopic Submucosal Dissection Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of Government Support, High prevalence of cancer, High healthcare expenditure and increasing investments in research and development. Asia Pacific is predicted to expand rapidly over the foreseeable period due to the region's rising risk of stomach Cancer.
Major market player included in this report are:
Olympus Corporation
Fujifilm Holdings Corporation
Boston Scientific Corporation
Medtronic
Sumitomo Bakelite Co., LTD
Ovesco Endoscopy AG
Zeon Corporation
Cook Group
ConMed Devices Private Limited
Erbe Elektromedizin GmbH

Recent Developments in the Market:
 In March 2021, Fujifilm Holdings Corporation acquired Hitachi, Ltd. With its entire solution, Fujifilm hopes to meet a variety of clinical requirements.
 In January 2021, to improve its surgical endoscopy capabilities, Olympus Corporation entered into an agreement to buy Quest Photonic Devices B.V. for up to EUR 50 million, including milestone payments.
Global Endoscopic Submucosal Dissection Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Indication, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Gastrosccopes and Colonoscopes
Knives
Injection Agents
Tissue Retractors
Graspers/Clips
Other Products
By Indication:
Stomach Cancer
Colon Cancer
Esophageal Cancer
By End User:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned
Olympus Corporation
Fujifilm Holdings Corporation
Boston Scientific Corporation
Medtronic
Sumitomo Bakelite Co., LTD
Ovesco Endoscopy AG
Zeon Corporation
Cook Group
ConMed Devices Private Limited
Erbe Elektromedizin GmbH

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.